Zobrazeno 1 - 10
of 211
pro vyhledávání: '"A. Aleksankin"'
Autor:
Anastasia S. Avdeeva, Andrey P. Aleksankin, Elena V. Tchetina, Yu. N. Gorbunova, Tatiana V. Popkova, Galina A. Markova, Tatiana A. Panafidina, Evgeny L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 4 (2024)
The aim – to evaluate subpopulations of B lymphocytes and features of interferon (IFN) status in patients with systemic lupus erythematosus (SLE), to clarify the relationship of immunological parameters with clinical manifestations of the diseaseMa
Externí odkaz:
https://doaj.org/article/eb2ddf7e6c8a42b8913fe921a4175133
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 5, Pp 513-530 (2023)
Uncontrolled activation of neutrophils is considered an important mechanism of thromboinflammation and fibrosis in immunemediated rheumatic diseases (IMRD), malignant neoplasms, atherosclerosis, COVID-19 and many other acute and chronic inflammatory
Externí odkaz:
https://doaj.org/article/d3211e5b41a5494abf2c79244a1638b6
Autor:
A. S. Avdeeva, A. P. Aleksankin, Zh. G. Verizhnikova, V. V. Rybakova, M. E. Diatroptov, Yu. N. Gorbunova, A. A. Mesnyankina, D. A. Paranich, A. M. Lila, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 13-18 (2023)
Objective: To study the frequency of spontaneous foci of DNA double-strand breaks (DSBs) in patients with immune-inflammatory rheumatic diseases (IIRD), their relationship to disease activity, levels of inflammatory markers, and levels of autoantibod
Externí odkaz:
https://doaj.org/article/bbc5ebb2f0504a76a9c547ed2dc38b83
Autor:
Eugene I. Goufman, Nataliia B. Tikhonova, Andrey P. Aleksankin, Karina B. Gershkovich, Alexander A. Stepanov, Irina I. Stepanova, Liudmila M. Mikhaleva, Natalia V. Nizyaeva, Olga V. Kovaleva, Alexander A. Alferov, Yury B. Kuzmin, Nikolay E. Kushlinskii
Publikováno v:
Diagnostics, Vol 14, Iss 13, p 1396 (2024)
Blood serum of patients with gastric (n = 68) and esophageal (n = 43) cancer was assessed for proteolytic fragments of IgG. Serum samples of 20 healthy donors were used as a control. We analyzed indicators of hemostasis (prothrombin time, fibrinogen,
Externí odkaz:
https://doaj.org/article/31352469157745778be8befeaa984628
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/1c93e633b55b4cd0b90e057591757b5e
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 38-45 (2022)
Objective: assessment of the dynamics of T- and B-lymphocytes subpopulations in rheumatoid arthritis (RA) during therapy with synthetic disease-modifying antirheumatic drugs (sDMARDs) and biological disease-modifying antirheumatic drugs (bDMARDs): in
Externí odkaz:
https://doaj.org/article/17ef735ea5fa4fdd81c88ecfb2655910
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 2, Pp 17-22 (2021)
Objective: to evaluate changes in T- and B-lymphocyte subpopulations at different stages of rheumatoid arthritis (RA).Patients and methods. The study included 53 patients with a definite RA diagnosis according to the 2010 ACR/EULAR criteria (mean age
Externí odkaz:
https://doaj.org/article/f16451cc9d3447f5aab95e789336a9f3
Autor:
L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The aim of our study was to assess the relationship between the changes of antinuclear autoantibodies (ANA) and autoantibodies to topoisomerase 1 (anti-Topo 1) in systemic sclerosis (SSc) patients on rituximab (RTX) therapy.Materials and methods. The
Externí odkaz:
https://doaj.org/article/8e773ad2e104498cbd62816d673a14cb
Autor:
L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 265-273 (2019)
The choice of drugs for the treatment of interstitial lung disease (ILD) associated with systemic sclerosis (SS) is currently very limited. Data from a number of studies show that rituximab (RTM) can improve lung function and reduce the severity of s
Externí odkaz:
https://doaj.org/article/fb2372c816e44d50a10380459139c10a